Summit Therapeutics Inc. Insider Transactions
Summit Therapeutics Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
DUGGAN ROBERT W
CEO |
Buy | 26,680 @ $18.74 | $499.98 K | 76,680 | 10/21/2025 | 10/23/2025 | |
|
Zanganeh Mahkam
CEO |
Buy | 26,680 @ $18.74 | $499.98 K | 76,680 | 10/21/2025 | 10/23/2025 | |
|
Zanganeh Mahkam
CEO |
Buy | 5,000 @ $18.07 | $90.35 K | 556,093,090 | 09/11/2025 | 09/11/2025 | |
|
DUGGAN ROBERT W
CEO |
Buy | 5,000 @ $18.07 | $90.35 K | 556,093,090 | 09/11/2025 | 09/11/2025 | |
|
Zanganeh Mahkam
CEO |
Buy | 333,394 @ $17.68 | $5.89 M | 556,088,090 | 09/10/2025 | 09/11/2025 | |
|
DUGGAN ROBERT W
CEO |
Buy | 333,394 @ $17.68 | $5.89 M | 556,088,090 | 09/10/2025 | 09/11/2025 | |
|
Zanganeh Mahkam
CEO |
Buy | 34,321 @ $3.72 | $127.67 K | 24,923,800 | 03/27/2024 | 03/27/2024 | |
|
Zanganeh Mahkam
CEO |
Buy | 26,000 @ $3.72 | $96.72 K | 520,814 | 03/27/2024 | 03/27/2024 | |
|
Zanganeh Mahkam
CEO |
Buy | 20,000 @ $3.71 | $74.20 K | 50,000 | 03/27/2024 | 03/27/2024 | |
|
Zanganeh Mahkam
CEO |
Buy | 30,000 @ $3.75 | $112.50 K | 30,000 | 03/26/2024 | 03/27/2024 | |
|
Dhingra Ankur
CFO |
Buy | 100,000 @ $3.75 | $375.00 K | 354,958 | 03/26/2024 | 03/27/2024 | |
|
Dhingra Ankur
CFO |
Buy | 19,700 @ $2.17 | $42.75 K | 254,958 | 12/13/2023 | 12/13/2023 | |
|
Dhingra Ankur
CFO |
Buy | 700 @ $2.15 | $1.51 K | 235,258 | 12/13/2023 | 12/13/2023 | |
|
Zanganeh Mahkam
CEO |
Buy | 5,000 @ $2.07 | $10.35 K | 494,814 | 12/12/2023 | 12/13/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Summit Therapeutics Inc. FAQ's
The list of insiders at Summit Therapeutics Inc. includes Zanganeh Mahkam, DUGGAN ROBERT W.
Insiders have purchased a total of 730.15 K Summit Therapeutics Inc. shares in the last 12 months for a total of 12.97 M.
The following insiders have purchased Summit Therapeutics Inc. shares in the last 12 months: Zanganeh Mahkam ($6.48 M), DUGGAN ROBERT W ($6.48 M),